Neuberger Berman Group
ARNA

Neuberger Berman Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Neuberger Berman Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-57,726
Closed -$4.01M – 1856
2021
Q1 		$4.01M Buy
57,726
+26
+0% +$2K ﹤0.01% 999
2020
Q4 		$4.43M Buy
57,700
+13,700
+31% +$1.03M ﹤0.01% 932
2020
Q3 		$3.29M Sell
44,000
-16,000
-27% -$1.07M ﹤0.01% 955
2020
Q2 		$3.78M Sell
60,000
-6
-0% -$330 ﹤0.01% 878
2020
Q1 		$2.52M Sell
60,006
-1
-0% -$46 ﹤0.01% 896
2019
Q4 		$2.73M Buy
60,007
+7
+0% +$331 ﹤0.01% 961
2019
Q3 		$2.75M Buy
60,000
+200
+0.3% +$11.2K ﹤0.01% 950
2019
Q2 		$3.51M Buy
59,800
+46,300
+343% +$2.39M ﹤0.01% 922
2019
Q1 		$605K Sell
13,500
-16,500
-55% -$757K ﹤0.01% 1211
2018
Q4 		$1.17M Buy
30,000
+25,000
+500% +$982K ﹤0.01% 1089
2018
Q3 		$230K Sell
5,000
-19,500
-80% -$790K ﹤0.01% 1528
2018
Q2 		$1.07M Sell
24,500
-6,500
-21% -$279K ﹤0.01% 1213
2018
Q1 		$1.23M Buy
+31,000
New +$1.21M ﹤0.01% 1129
2013
Q3 		– Sell
-4,587
Closed -$353K – 1689
2013
Q2 		$353K Buy
+4,587
New +$374K ﹤0.01% 1367

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group's ARNA Position: Q2 2021 in Review

Neuberger Berman Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2021, closing a stake of 57,726 shares — an estimated $4.01M sold.

Neuberger Berman Group first reported a position in ARNA in Q2 2013 and held it in 14 quarters. The position peaked at $4.43M in Q4 2020. 237 funds tracked by Wall St. Rank hold ARNA as of Q2 2021.

  • Neuberger Berman Group reported no remaining Arena Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
  • Neuberger Berman Group sold 57,726 Arena Pharmaceuticals Inc shares in Q2 2021, an estimated $4.01M.
  • Neuberger Berman Group first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 14 quarters.
  • Neuberger Berman Group's Arena Pharmaceuticals Inc position peaked at $4.43M in Q4 2020.
  • 237 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2021.

Based on Neuberger Berman Group's 13F filing for Q2 2021, filed 13 Aug 2021.